Centrifugal Blood Pumps Market size was valued at around USD 100.5 million in 2024 and is anticipated to surpass USD 191 million by 2037, registering a CAGR of 5.5% during the forecast timeline i.e. 2025-2037. In 2025, the industry size of centrifugal blood pumps is evaluated at USD 106 million. As the aged population and the diseases related to cardiovascular conditions rise, so do the requirements for CVD treatments such as centrifugal blood pumps also grow. For instance, according to a WHO report published in June 2021, 17.9 million deaths were caused in the year 2019, owing to cardiovascular diseases (CVDs), representing 32% of global deaths.
In addition, the centrifugal blood pumps market is expanding due to the use of minimally invasive surgical techniques and advancements in pump design that improve patient outcomes and performance. For instance, as per the National Library of Medicine in March 2024, the performance of the centrifugal pump used as a ventricular assist device was simulated using ANSYS CFX 17.0 software. In addition, a configuration with a 45° inlet and 55° outlet angle was found to improve the functionality, increasing the total head by at least 20%. These numerical simulations were validated using a benchmark pump supplied by the US Food and Drug Administration (FDA).
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.5% |
|
Base Year Market Size (2024) |
USD 100.5 million |
|
Forecast Year Market Size (2037) |
USD 191 million |
|
Regional Scope |
|
Product Type (Electrical, Mechanical)
Based on product type electrical segment is projected to dominate centrifugal blood pumps market share of around 77.2% by the end of 2037. Compared to roller pumps, electronic centrifugal blood pumps have the advantage of a less noticeable systemic inflammatory response and less damage to red blood cells, which promotes segment growth. For instance, in February 2023, it was published in Micromachines that a screw centrifugal blood pump was examined with a multi-objective gray wolf optimization algorithm in addition to a random forest optimization method. The hemolysis value dropped by 48% and the pressure generation increased by 24%. Thus, technical breakthroughs are serving as a catalyst for the growth in the market.
Application (Short-Term Support, Long-Term Support)
The long-term support segment in the centrifugal blood pumps market is likely to garner lucrative growth opportunities during the forecast period. The increasing need for long-term solutions to manage chronic cardiovascular conditions is further fueling the demand in the market. These systems have become indispensable instruments in the management of complex cardiovascular conditions. In addition, technological advancements in long-term support systems have improved their reliability and patient comfort. For instance, in May 2024, as per news published by the Food & Drug Administration, HeartMate 3 LVAS, by Abbott Laboratories can be used in adults and pediatric patients with severe left ventricular heart failure. This system can be used for both short- and long-term support.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Application |
|
|
End user |
|
North America Market Statistics
North America centrifugal blood pumps market is set to dominate revenue share of around 43.1% by the end of 2037. It has been influenced by technological advancement and the occurrence of cardiovascular diseases. This region has a well-established health infrastructure with strong investment in research and development, which supports the introduction of new-age devices. Regulatory support on the part of organizations such as the FDA also plays an important role in speeding up the approvals of products, which in turn is helping market growth.
Throughout the forecast period, the market in the U.S. is anticipated to grow substantially. In addition, it is evolving due to increasing technological progress and the rising number of heart surgeries. For instance, in August 2023, news published by the National Library of Medicine stated that the U.S. performed about 400,000 coronary artery bypass grafting (CABG) surgeries yearly. This reflects the high prevalence of cardiovascular diseases in the country.
Canada is witnessing a noteworthy growth in the centrifugal blood pumps market attributable to innovations and advancements in cardiac support and artificial circulations. In addition, the companies are focusing on miniaturization and integration of sensors in bringing efficacy into monitoring operations. For instance, in January 2020, Synaptive Medical developed an innovative imaging and surgical tool, Modus V to enhance miniaturization in surgical precision and assist in delivering better patient care.
Asia Pacific Market Analysis
The Asia Pacific is establishing itself as an opportunistic centrifugal blood pumps market, driven by growing healthcare expenditure along with a general rise in the awareness of advanced medical technologies. In addition, the medical tourism sector is booming, and this market would expand further with demand from cross-border patients for sophisticated surgical procedures. There are strategic local manufacturers which tend to join hands with overseas firms also in advancing and offering new centrifugal blood pumps for better distribution.
India's government programs in the centrifugal blood pumps market aim to improve the healthcare infrastructure which made cardiac care technologies more accessible in urban and rural areas. Through its MedTech programs that gained significance over the years, the local government continue to promote innovation in cardiac care. For instance, in August 2024 a news published by the National Library of Medicine stated that PubMed Central developed a pediatric total artificial heart (TAH). It flows continuously with magnetic levitation. A single, small housing design supports a centrifugal blood pump in the hybrid TAH design.
The centrifugal blood pumps market in China is anticipated to expand significantly, attributable to the strong presence of healthcare companies and their endeavor in continuous innovation. For instance, in October 2021, Jiangsu STMed Technology Co. Ltd. developed a new centrifugal blood pump called the STM CP-24 I ECMO, specifically designed for the OASSIST ECMO system. This system has a separate control console centrifugal pump driver that can record pertinent parameters in real-time and combines the capabilities of flow signal sensing and processing.
The centrifugal blood pumps market is diversified by company type, ranging from well-established companies in the medical device business to emerging startups, all of which are looking to innovate and improve cardiac support technologies. Companies are leveraging their extensive research capabilities and distribution networks to their advantage in offering more extensive product offerings. In addition, companies are directing efforts toward the miniaturization of pumps and easier integration into clinical workflows.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?